Pemetrexed Disodium Hemipentahydrate is a chemotherapy drug mainly used to treat malignant pleural mesothelioma and non-squamous non-small cell lung cancer (NSCLC). It is often used in combination with cisplatin or other platinum-based chemotherapy drugs, and also as maintenance therapy or second-line treatment in NSCLC cases. Its therapeutic use is listed as antineoplastics. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Alimta and Pemetrexed sodium hydrate (2:4:5). Its PubChem CID is 135564527.
Pemetrexed disodium hemipentahydrate
| CAS No | 357166-30-4 |
|---|---|
| Molecular Formula | C40H48N10Na4O17 |
| Molecular Weight | 1032.8 g/mol |
| Synonyms | tetrasodium;(2S)-2-[[4-[2-(2-amino-4-oxo-3,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioate;pentahydrate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Pemetrexed Disodium Hemipentahydrate is a chemotherapy drug mainly used to treat malignant pleural mesothelioma and non-squamous non-small cell lung cancer (NSCLC).
The listed CAS number is 357166-30-4.
The listed molecular formula is C40H48N10Na4O17.
The listed molecular weight is 1032.8 g/mol.
tetrasodium;(2S)-2-[[4-[2-(2-amino-4-oxo-3,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioate;pentahydrate.
The source lists Alimta and Pemetrexed sodium hydrate (2:4:5).